Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant
Clinical trial NCT04317781 · TERMINATED
Trial details
- NCT number
- NCT04317781
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-27
- Primary completion
- 2023-07-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.